• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 15-12B filed by Apria Inc.

    4/8/22 10:10:58 AM ET
    $APR
    Medical/Dental Instruments
    Health Care
    Get the next $APR alert in real time by email
    15-12B 1 d343965d1512b.htm 15-12B 15-12B

    As filed with the Securities and Exchange Commission on April 8, 2022

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 15

     

     

    CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

    UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

    OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

    OF THE SECURITIES ACT OF 1934.

    Commission File Number: 001-40053

     

     

    Apria, Inc.

    (Exact name of registrant as specified in its charter)

     

     

    7353 Company Drive

    Indianapolis, Indiana 46237

    (800) 990-9799

    (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

     

     

    Common Stock, par value $0.01 per share

    (Title of each class of securities covered by this Form)

    None

    (Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

     

     

    Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

     

    Rule 12g-4(a)(1)    ☒
    Rule 12g-4(a)(2)    ☐
    Rule 12h-3(b)(1)(i)    ☒
    Rule 12h-3(b)(1)(ii)    ☐
    Rule 15d-6    ☐
    Rule 15d-22(b)    ☐

    Approximate number of holders of record as of the certification or notice date: 2

     

     

     


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, Apria, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

    Date: April 8, 2022

    APRIA, INC.
    By:  

    /s/ Nicholas J. Pace

      Name: Nicholas J. Pace
      Title: Director
    Get the next $APR alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $APR

    DatePrice TargetRatingAnalyst
    1/11/2022$37.50Buy → Neutral
    UBS
    1/10/2022$39.00Buy
    Citigroup
    11/19/2021$39.00Buy
    Citigroup
    11/8/2021$43.00Buy
    Citigroup
    7/19/2021$32.00 → $29.00Buy → Neutral
    Goldman Sachs
    6/30/2021$33.00Buy
    Citigroup
    More analyst ratings

    $APR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Apria Announces Financial Results for Fourth Quarter and Full Year 2021

    INDIANAPOLIS, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR), a leading provider of integrated home healthcare equipment and related services in the United States, announced today financial results for the fourth quarter and full year ended December 31, 2021. As previously announced, the Company will not be hosting a conference call to discuss its financial results. "We reported solid fourth quarter financial results and 2021 was a good year for Apria. Our team did an excellent job operating and executing at a high level while navigating the challenges from the COVID-19 pandemic, as well as a major product recall and supply chain constraints. Fourth

    2/28/22 6:30:00 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    Apria Announces Expiration of Hart-Scott-Rodino Waiting Period

    INDIANAPOLIS, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR), a leading provider of home medical equipment, supplies and related services in the United States, announced today that the waiting period has expired under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection with its previously announced transaction with Owens & Minor, Inc. The closing of the transaction remains subject to approval by holders of a majority of the Company's outstanding common stock and other customary closing conditions. About Apria Apria is a leading provider of integrated home healthcare equipment and related services in the United States,

    2/24/22 4:05:00 PM ET
    $APR
    Medical/Dental Instruments
    Health Care

    Owens & Minor, Inc. Signs Definitive Agreement to Acquire Apria, Inc.

    Highly Complementary Transaction Expands Patient Direct Offering Year-One Accretion Across Key Financial Metrics and Free Cash Flow Enhancement Creates a Leading Platform for Future Growth Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) and Apria, Inc. ("Apria") (NASDAQ:APR) today announced that the companies have entered into a definitive agreement pursuant to which Owens & Minor will acquire Apria for $37.50 in cash per share of common stock, representing an equity value of approximately $1.45 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220110005291/en/ "I'm very excited about the acquisition of Apria, which wil

    1/10/22 6:00:00 AM ET
    $APR
    $OMI
    Medical/Dental Instruments
    Health Care
    Medical Specialities

    $APR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $APR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $APR
    SEC Filings

    View All

    Apria downgraded by UBS with a new price target

    UBS downgraded Apria from Buy to Neutral and set a new price target of $37.50

    1/11/22 6:43:54 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    Citigroup resumed coverage on Apria with a new price target

    Citigroup resumed coverage of Apria with a rating of Buy and set a new price target of $39.00

    1/10/22 7:15:48 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    Citigroup resumed coverage on Apria with a new price target

    Citigroup resumed coverage of Apria with a rating of Buy and set a new price target of $39.00

    11/19/21 7:12:27 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    SEC Form 4: Walker Robert P. returned $192,450 worth of shares to the company (5,132 units at $37.50), closing all direct ownership in the company (tax liability)

    4 - Apria, Inc. (0001735803) (Issuer)

    3/29/22 4:31:49 PM ET
    $APR
    Medical/Dental Instruments
    Health Care

    SEC Form 4: Apria Holdings Llc sold $532,031,812 worth of shares (14,187,515 units at $37.50)

    4 - Apria, Inc. (0001735803) (Issuer)

    3/29/22 4:31:15 PM ET
    $APR
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Snyder Lynn Shapiro to satisfy withholding obligation

    4 - Apria, Inc. (0001735803) (Issuer)

    3/29/22 4:31:20 PM ET
    $APR
    Medical/Dental Instruments
    Health Care

    SEC Form 15-12B filed by Apria Inc.

    15-12B - Apria, Inc. (0001735803) (Filer)

    4/8/22 10:10:58 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    SEC Form 25-NSE filed by Apria Inc.

    25-NSE - Apria, Inc. (0001735803) (Subject)

    3/29/22 8:55:14 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    SEC Form S-8 POS filed by Apria Inc.

    S-8 POS - Apria, Inc. (0001735803) (Filer)

    3/29/22 8:35:01 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    $APR
    Financials

    Live finance-specific insights

    View All

    Owens & Minor, Inc. Signs Definitive Agreement to Acquire Apria, Inc.

    Highly Complementary Transaction Expands Patient Direct Offering Year-One Accretion Across Key Financial Metrics and Free Cash Flow Enhancement Creates a Leading Platform for Future Growth Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) and Apria, Inc. ("Apria") (NASDAQ:APR) today announced that the companies have entered into a definitive agreement pursuant to which Owens & Minor will acquire Apria for $37.50 in cash per share of common stock, representing an equity value of approximately $1.45 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220110005291/en/ "I'm very excited about the acquisition of Apria, which wil

    1/10/22 6:00:00 AM ET
    $APR
    $OMI
    Medical/Dental Instruments
    Health Care
    Medical Specialities

    Apria to Announce Third Quarter 2021 Financial Results

    INDIANAPOLIS, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR) announced today that it will release fiscal third quarter 2021 financial results on Thursday, November 4, 2021 after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. (ET) on the same day. Conference Call Details The conference call can be accessed by dialing (833) 362-0207 for U.S. participants, or (914) 987-7676 for international participants, referencing conference ID 4161279; or via a live audio webcast that will be available online at https://ir.apria.com/. A replay of the call will be available via webcast for on-demand listeni

    10/21/21 8:00:00 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    Apria to Announce Second Quarter 2021 Financial Results

    INDIANAPOLIS, July 22, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR) announced today that it will release fiscal second quarter 2021 financial results on Thursday, August 5, 2021 after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. (ET) on the same day. Conference Call Details The conference call can be accessed by dialing (833) 362-0207 for U.S. participants, or (914) 987-7676 for international participants, referencing conference ID # 5380517; or via a live audio webcast that will be available online at https://ir.apria.com/. A replay of the call will be available via webcast for on-demand listen

    7/22/21 4:05:00 PM ET
    $APR
    Medical/Dental Instruments
    Health Care

    $APR
    Leadership Updates

    Live Leadership Updates

    View All

    Apria Appoints Christopher G. Lee as Chief Accounting Officer

    INDIANAPOLIS, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR), a leading provider of home medical equipment, supplies and related services in the United States, announced today the appointment of Christopher G. Lee as Chief Accounting Officer, a newly created position. Mr. Lee will report to Debra Morris, Apria's Chief Financial Officer. Mr. Lee has 18 years of accounting and financial leadership experience. He joined Apria in February 2009 and has risen internally to his most recent role as Senior Vice President, Accounting and Finance. Prior to joining Apria, Mr. Lee was with Deloitte & Touche. Mr. Lee is a graduate of the University of California a

    10/4/21 8:00:00 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    $APR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Apria Inc. (Amendment)

    SC 13G/A - Apria, Inc. (0001735803) (Subject)

    4/8/22 4:04:00 PM ET
    $APR
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Apria Inc.

    SC 13G - Apria, Inc. (0001735803) (Subject)

    3/10/22 5:01:54 PM ET
    $APR
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Apria Inc.

    SC 13G - Apria, Inc. (0001735803) (Subject)

    2/14/22 4:06:09 PM ET
    $APR
    Medical/Dental Instruments
    Health Care